High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research

Project Information

TUMOURPRINT

Grant agreement ID: 829846

DOI 10.3030/829846

Project closed

EC signature date 29 October 2018

Start date 1 September 2018

End date 31 January 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 500 467,50

EU contribution € 2 450 327,25

Coordinated by

BICO GROUP AB
Sweden

Deliverables

Documents, reports (3)

CE- and LVD certificates
Cancer cell lines selected
Life-cycle assessment report

Demonstrators, pilots, prototypes (2)

Trademarked product name
10 hired employees

Websites, patent fillings, videos etc. (2)

Project dedicated Website tab launched
Marketing material